Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.

被引：0
|
作者：
Weiss, MA [1 ]
Lamanna, N [1 ]
Gencarelli, A [1 ]
Scheinberg, DA [1 ]
Maslak, PG [1 ]
Horgan, D [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5019
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [1] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    Foon, Kenneth A.
    Boyiadzis, Michael
    Land, Stephanie R.
    Marks, Stanley
    Raptis, Anastasios
    Pietragallo, Louis
    Meisner, Dennis
    Laman, Andrew
    Sulecki, Mathew
    Butchko, Allyson
    Schaefer, Patricia
    Lenzer, Diana
    Tarhini, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 498 - 503
  • [2] Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia.
    Short, Nicholas James
    Keating, Michael J.
    Wierda, William G.
    Faderl, Stefan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Smith, Susan C.
    O'Brien, Susan Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab induces a high incidence of complete response in patients with chronic lymphocytic leukemia (CLL).
    Lamanna, N
    Weiss, MA
    Maslak, PG
    Gencarelli, AN
    Scheinberg, DA
    Horgan, D
    BLOOD, 2003, 102 (11) : 440A - 440A
  • [4] Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses
    Lamanna, Nicole
    Jurcic, Joseph G.
    Noy, Ariela
    Maslak, Peter
    Gencarelli, Alison N.
    Panageas, Katherine S.
    Heaney, Mark L.
    Brentjens, Renier J.
    Golde, David W.
    Scheinberg, David A.
    Zelenetz, Andrew D.
    Weiss, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 491 - 497
  • [5] Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Weiss, MA
    Glenn, M
    Maslak, P
    Rahman, Z
    Noy, A
    Zelenetz, A
    Scheinberg, DA
    Golde, DW
    LEUKEMIA, 2000, 14 (09) : 1577 - 1582
  • [6] Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    MA Weiss
    M Glenn
    P Maslak
    Z Rahman
    A Noy
    A Zelenetz
    DA Scheinberg
    DW Golde
    Leukemia, 2000, 14 : 1577 - 1582
  • [7] A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
    Izutsu, Koji
    Kinoshita, Tomohiro
    Takizawa, Jun
    Fukuhara, Suguru
    Yamamoto, Go
    Ohashi, Yasuo
    Suzumiya, Junji
    Tobinai, Kensei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 408 - 415
  • [8] COST-EFFECTIVENESS OF RITUXIMAB COMBINED WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN FRANCE
    Roussel, M.
    Troussard, X.
    Delmer, A.
    Poinso, M.
    Miadi-Fargier, H.
    VALUE IN HEALTH, 2009, 12 (07) : A270 - A270
  • [9] Oral fludarabine and cyclophosphamide plus rituximab in the treatment of the chronic lymphocytic leukemia.
    Casula, P
    Sorano, G
    Pulixi, D
    Culurgioni, F
    Angelucci, E
    BLOOD, 2005, 106 (11) : 341B - 342B
  • [10] Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia
    Hornberger, John
    Reyes, Carolina
    Shewade, Ashwini
    Lerner, Susan
    Friedmann, Mark
    Han, Leona
    Gutierrez, Hialy
    Satram-Hoang, Sacha
    Keating, Michael J.
    LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 225 - 234
12345